Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18 F-FPEB and 1 H-MRS study in rats.

de Laat B, Weerasekera A, Leurquin-Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K.

Addict Biol. 2018 May 23. doi: 10.1111/adb.12635. [Epub ahead of print]

PMID:
29790622
2.

The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.

Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I, Himmelreich U, Verfaillie CM, Sampaolesi M, Deroose CM.

Theranostics. 2018 Apr 14;8(10):2799-2813. doi: 10.7150/thno.22980. eCollection 2018.

3.

A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis.

Poelmans J, Himmelreich U, Vanherp L, Zhai L, Hillen A, Holvoet B, Belderbos S, Brock M, Maertens J, Velde GV, Lagrou K.

Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00240-18. doi: 10.1128/AAC.00240-18. [Epub ahead of print]

PMID:
29760132
4.

Tri-modal In vivo Imaging of Pancreatic Islets Transplanted Subcutaneously in Mice.

Liang S, Louchami K, Holvoet B, Verbeke R, Deroose CM, Manshian B, Soenen SJ, Lentacker I, Himmelreich U.

Mol Imaging Biol. 2018 Apr 18. doi: 10.1007/s11307-018-1192-0. [Epub ahead of print]

PMID:
29671177
5.

A Magnetic Chameleon: Biocompatible Lanthanide Fluoride Nanoparticles with Magnetic Field Dependent Tunable Contrast Properties as a Versatile Contrast Agent for Low to Ultrahigh Field MRI and Optical Imaging in Biological Window.

Biju S, Gallo J, Bañobre-López M, Manshian BB, Soenen SJ, Himmelreich U, Vander Elst L, Parac-Vogt TN.

Chemistry. 2018 May 23;24(29):7388-7397. doi: 10.1002/chem.201800283. Epub 2018 Apr 26.

PMID:
29575427
6.

Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.

Vande Velde G, Kucharíková S, Van Dijck P, Himmelreich U.

Int J Antimicrob Agents. 2018 Mar 20. pii: S0924-8579(18)30078-5. doi: 10.1016/j.ijantimicag.2018.03.007. [Epub ahead of print]

PMID:
29572043
7.

Improved Labeling of Pancreatic Islets Using Cationic Magnetoliposomes.

Garcia Ribeiro RS, Ketkar-Atre A, Yin T, Louchami K, Struys T, Lambrichts I, Sener A, Malaisse WJ, De Cuyper M, Himmelreich U.

J Pers Med. 2018 Mar 12;8(1). pii: E12. doi: 10.3390/jpm8010012.

8.

Multipotent Adult Progenitor Cells Support Lymphatic Regeneration at Multiple Anatomical Levels during Wound Healing and Lymphedema.

Beerens M, Aranguren XL, Hendrickx B, Dheedene W, Dresselaers T, Himmelreich U, Verfaillie C, Luttun A.

Sci Rep. 2018 Mar 1;8(1):3852. doi: 10.1038/s41598-018-21610-8.

9.

Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats.

de Laat B, Weerasekera A, Leurquin-Sterk G, Bormans G, Himmelreich U, Casteels C, Van Laere K.

J Nucl Med. 2018 Jun;59(6):952-959. doi: 10.2967/jnumed.117.202614. Epub 2018 Mar 1.

PMID:
29496988
10.

Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice.

Vanherp L, Poelmans J, Hillen A, Govaerts K, Belderbos S, Buelens T, Lagrou K, Himmelreich U, Vande Velde G.

Sci Rep. 2018 Feb 14;8(1):3009. doi: 10.1038/s41598-018-20545-4.

11.

High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease.

Salas IH, Weerasekera A, Ahmed T, Callaerts-Vegh Z, Himmelreich U, D'Hooge R, Balschun D, Saido TC, De Strooper B, Dotti CG.

Neurobiol Dis. 2018 May;113:82-96. doi: 10.1016/j.nbd.2018.02.001. Epub 2018 Feb 7.

PMID:
29427755
12.

Nanoparticle-induced inflammation can increase tumor malignancy.

Manshian BB, Poelmans J, Saini S, Pokhrel S, Grez JJ, Himmelreich U, Mädler L, Soenen SJ.

Acta Biomater. 2018 Mar 1;68:99-112. doi: 10.1016/j.actbio.2017.12.020. Epub 2017 Dec 20.

PMID:
29274476
13.

Pretargeted PET Imaging Using a Bioorthogonal 18F-Labeled trans-Cyclooctene in an Ovarian Carcinoma Model.

Billaud EMF, Belderbos S, Cleeren F, Maes W, Van de Wouwer M, Koole M, Verbruggen A, Himmelreich U, Geukens N, Bormans G.

Bioconjug Chem. 2017 Dec 20;28(12):2915-2920. doi: 10.1021/acs.bioconjchem.7b00635. Epub 2017 Dec 11.

PMID:
29191024
14.

NOD mice, susceptible to pancreatic autoimmunity, demonstrate delayed growth of pancreatic cancer.

Dooley J, Pasciuto E, Lagou V, Lampi Y, Dresselaers T, Himmelreich U, Liston A.

Oncotarget. 2017 Sep 24;8(46):80167-80174. doi: 10.18632/oncotarget.21261. eCollection 2017 Oct 6.

15.

Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.

Crabbé M, Van der Perren A, Weerasekera A, Himmelreich U, Baekelandt V, Van Laere K, Casteels C.

Neurobiol Aging. 2018 Jan;61:82-92. doi: 10.1016/j.neurobiolaging.2017.09.006. Epub 2017 Sep 21.

PMID:
29055799
16.

Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.

Deckx S, Heggermont W, Carai P, Rienks M, Dresselaers T, Himmelreich U, van Leeuwen R, Lommen W, van der Velden J, Gonzalez A, Diez J, Papageorgiou AP, Heymans S.

Matrix Biol. 2018 Mar;66:110-124. doi: 10.1016/j.matbio.2017.09.002. Epub 2017 Sep 25.

PMID:
28958774
17.

Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.

Yin T, Liu Y, Peeters R, Feng Y, Yu J, Himmelreich U, Oyen R, Ni Y.

Br J Cancer. 2017 Nov 7;117(10):1529-1536. doi: 10.1038/bjc.2017.324. Epub 2017 Sep 14.

PMID:
28910821
18.

Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P.

Liu Y, Yin T, Keyzer F, Feng Y, Chen F, Liu J, Song S, Yu J, Vandecaveye V, Swinnen J, Bormans G, Himmelreich U, Oyen R, Zhang J, Huang G, Ni Y.

Oncotarget. 2017 Jul 18;8(33):55204-55215. doi: 10.18632/oncotarget.19339. eCollection 2017 Aug 15.

19.

Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.

Leurquin-Sterk G, Ceccarini J, Crunelle CL, Weerasekera A, de Laat B, Himmelreich U, Bormans G, Van Laere K.

Addict Biol. 2018 May;23(3):931-944. doi: 10.1111/adb.12542. Epub 2017 Sep 8.

PMID:
28884874
20.

Clinical Metabolomics and Glaucoma.

Barbosa-Breda J, Himmelreich U, Ghesquière B, Rocha-Sousa A, Stalmans I.

Ophthalmic Res. 2018;59(1):1-6. doi: 10.1159/000479158. Epub 2017 Sep 1. Review.

21.

The successive projection algorithm as an initialization method for brain tumor segmentation using non-negative matrix factorization.

Sauwen N, Acou M, Bharath HN, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Van Huffel S.

PLoS One. 2017 Aug 28;12(8):e0180268. doi: 10.1371/journal.pone.0180268. eCollection 2017.

22.

Comparison of different compressed sensing algorithms for low SNR 19 F MRI applications-Imaging of transplanted pancreatic islets and cells labeled with perfluorocarbons.

Liang S, Dresselaers T, Louchami K, Zhu C, Liu Y, Himmelreich U.

NMR Biomed. 2017 Nov;30(11). doi: 10.1002/nbm.3776. Epub 2017 Aug 25.

PMID:
28841762
23.

Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.

Muthuramu I, Amin R, Postnov A, Mishra M, Aboumsallem JP, Dresselaers T, Himmelreich U, Van Veldhoven PP, Gheysens O, Jacobs F, De Geest B.

Mol Ther. 2017 Nov 1;25(11):2513-2525. doi: 10.1016/j.ymthe.2017.07.017. Epub 2017 Aug 1.

PMID:
28822689
24.

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging.

Hachani R, Birchall MA, Lowdell MW, Kasparis G, Tung LD, Manshian BB, Soenen SJ, Gsell W, Himmelreich U, Gharagouzloo CA, Sridhar S, Thanh NTK.

Sci Rep. 2017 Aug 10;7(1):7850. doi: 10.1038/s41598-017-08092-w.

25.

Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation.

Dooley J, Lagou V, Heirman N, Dresselaers T, Himmelreich U, Liston A.

Front Oncol. 2017 Jun 28;7:133. doi: 10.3389/fonc.2017.00133. eCollection 2017.

26.

The role of intracellular trafficking of CdSe/ZnS QDs on their consequent toxicity profile.

Manshian BB, Martens TF, Kantner K, Braeckmans K, De Smedt SC, Demeester J, Jenkins GJS, Parak WJ, Pelaz B, Doak SH, Himmelreich U, Soenen SJ.

J Nanobiotechnology. 2017 Jun 15;15(1):45. doi: 10.1186/s12951-017-0279-0.

27.

No Functional Role for microRNA-342 in a Mouse Model of Pancreatic Acinar Carcinoma.

Dooley J, Lagou V, Pasciuto E, Linterman MA, Prosser HM, Himmelreich U, Liston A.

Front Oncol. 2017 May 18;7:101. doi: 10.3389/fonc.2017.00101. eCollection 2017.

28.

Semi-automated brain tumor segmentation on multi-parametric MRI using regularized non-negative matrix factorization.

Sauwen N, Acou M, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Huffel SV.

BMC Med Imaging. 2017 May 4;17(1):29. doi: 10.1186/s12880-017-0198-4.

29.

miR-29a-deficiency does not modify the course of murine pancreatic acinar carcinoma.

Dooley J, Lagou V, Garcia-Perez JE, Himmelreich U, Liston A.

Oncotarget. 2017 Apr 18;8(16):26911-26917. doi: 10.18632/oncotarget.15850.

30.

Personalized medicine and follow-up of therapeutic delivery through exploitation of quantum dot toxicity.

Manshian BB, Jiménez J, Himmelreich U, Soenen SJ.

Biomaterials. 2017 May;127:1-12. doi: 10.1016/j.biomaterials.2017.02.039. Epub 2017 Mar 6.

PMID:
28273498
31.

No Effect of Dietary Aspartame or Stevia on Pancreatic Acinar Carcinoma Development, Growth, or Induced Mortality in a Murine Model.

Dooley J, Lagou V, Dresselaers T, van Dongen KA, Himmelreich U, Liston A.

Front Oncol. 2017 Feb 9;7:18. doi: 10.3389/fonc.2017.00018. eCollection 2017.

32.

In Silico Design of Optimal Dissolution Kinetics of Fe-Doped ZnO Nanoparticles Results in Cancer-Specific Toxicity in a Preclinical Rodent Model.

Manshian BB, Pokhrel S, Himmelreich U, Tämm K, Sikk L, Fernández A, Rallo R, Tamm T, Mädler L, Soenen SJ.

Adv Healthc Mater. 2017 May;6(9). doi: 10.1002/adhm.201601379. Epub 2017 Feb 23.

PMID:
28230930
33.

Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars.

D'Hollander A, Jans H, Velde GV, Verstraete C, Massa S, Devoogdt N, Stakenborg T, Muyldermans S, Lagae L, Himmelreich U.

Biomaterials. 2017 Apr;123:15-23. doi: 10.1016/j.biomaterials.2017.01.007. Epub 2017 Jan 6.

PMID:
28152380
34.

Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features.

Ion-Mărgineanu A, Van Cauter S, Sima DM, Maes F, Sunaert S, Himmelreich U, Van Huffel S.

Front Neurosci. 2017 Jan 11;10:615. doi: 10.3389/fnins.2016.00615. eCollection 2016.

35.

Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia.

Argibay B, Trekker J, Himmelreich U, Beiras A, Topete A, Taboada P, Pérez-Mato M, Vieites-Prado A, Iglesias-Rey R, Rivas J, Planas AM, Sobrino T, Castillo J, Campos F.

Sci Rep. 2017 Jan 16;7:40758. doi: 10.1038/srep40758.

36.

An advanced MRI and MRSI data fusion scheme for enhancing unsupervised brain tumor differentiation.

Li Y, Liu X, Wei F, Sima DM, Van Cauter S, Himmelreich U, Pi Y, Hu G, Yao Y, Van Huffel S.

Comput Biol Med. 2017 Feb 1;81:121-129. doi: 10.1016/j.compbiomed.2016.12.017. Epub 2016 Dec 27.

PMID:
28061367
37.

Visualization, Quantification and Characterization of Caerulein-Induced Acute Pancreatitis in Rats by 3.0T Clinical MRI, Biochemistry and Histomorphology.

Yin T, Peeters R, Liu Y, Feng Y, Zhang X, Jiang Y, Yu J, Dymarkowski S, Himmelreich U, Oyen R, Ni Y.

Theranostics. 2017 Jan 1;7(2):285-294. doi: 10.7150/thno.16282. eCollection 2017.

38.

Characterization of a rat orthotopic pancreatic head tumor model using three-dimensional and quantitative multi-parametric MRI.

Yin T, Peeters R, Feng Y, Liu Y, Yu J, Dymarkowski S, Himmelreich U, Oyen R, Ni Y.

NMR Biomed. 2017 Feb;30(2). doi: 10.1002/nbm.3676. Epub 2016 Dec 23.

PMID:
28008670
39.

Standard Cellular Testing Conditions Generate an Exaggerated Nanoparticle Cytotoxicity Profile.

Manshian BB, Himmelreich U, Soenen SJ.

Chem Res Toxicol. 2017 Feb 20;30(2):595-603. doi: 10.1021/acs.chemrestox.6b00340. Epub 2016 Dec 16.

PMID:
27982583
40.

Image-based in vivo assessment of targeting accuracy of stereotactic brain surgery in experimental rodent models.

Rangarajan JR, Vande Velde G, van Gent F, De Vloo P, Dresselaers T, Depypere M, van Kuyck K, Nuttin B, Himmelreich U, Maes F.

Sci Rep. 2016 Nov 30;6:38058. doi: 10.1038/srep38058.

41.

Presence of an Immune System Increases Anti-Tumor Effect of Ag Nanoparticle Treated Mice.

Manshian BB, Jimenez J, Himmelreich U, Soenen SJ.

Adv Healthc Mater. 2017 Jan;6(1). doi: 10.1002/adhm.201601099. Epub 2016 Nov 25.

PMID:
27885834
42.

Nuclear Magnetic Resonance Spectroscopy-Based Identification of Yeast.

Himmelreich U, Sorrell TC, Daniel HM.

Methods Mol Biol. 2017;1508:289-304.

PMID:
27837512
43.

Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.

Sauwen N, Acou M, Van Cauter S, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Van Huffel S.

Neuroimage Clin. 2016 Sep 30;12:753-764. eCollection 2016.

44.

Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study.

Leurquin-Sterk G, Van den Stock J, Crunelle CL, de Laat B, Weerasekera A, Himmelreich U, Bormans G, Van Laere K.

J Nucl Med. 2016 Nov;57(11):1746-1752. Epub 2016 Jun 9.

45.

Cytosolic Delivery of Nanolabels Prevents Their Asymmetric Inheritance and Enables Extended Quantitative in Vivo Cell Imaging.

Xiong R, Joris F, Liang S, De Rycke R, Lippens S, Demeester J, Skirtach A, Raemdonck K, Himmelreich U, De Smedt SC, Braeckmans K.

Nano Lett. 2016 Oct 3. [Epub ahead of print]

PMID:
27684962
46.

In vivo and ex vivo 19-fluorine magnetic resonance imaging and spectroscopy of beta-cells and pancreatic islets using GLUT-2 specific contrast agents.

Liang S, Louchami K, Kolster H, Jacobsen A, Zhang Y, Thimm J, Sener A, Thiem J, Malaisse W, Dresselaers T, Himmelreich U.

Contrast Media Mol Imaging. 2016 Nov;11(6):506-513. doi: 10.1002/cmmi.1712. Epub 2016 Sep 14.

PMID:
27624753
47.

Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging.

D'Hollander A, Mathieu E, Jans H, Vande Velde G, Stakenborg T, Van Dorpe P, Himmelreich U, Lagae L.

Int J Nanomedicine. 2016 Aug 4;11:3703-14. doi: 10.2147/IJN.S91340. eCollection 2016.

48.

Nonnegative Canonical Polyadic Decomposition for Tissue-Type Differentiation in Gliomas.

Bharath HN, Sima DM, Sauwen N, Himmelreich U, De Lathauwer L, Van Huffel S.

IEEE J Biomed Health Inform. 2017 Jul;21(4):1124-1132. doi: 10.1109/JBHI.2016.2583539. Epub 2016 Jul 14.

PMID:
27429452
49.

Evaluation of quantum dot cytotoxicity: interpretation of nanoparticle concentrations versus intracellular nanoparticle numbers.

Manshian BB, Abdelmonem AM, Kantner K, Pelaz B, Klapper M, Nardi Tironi C, Parak WJ, Himmelreich U, Soenen SJ.

Nanotoxicology. 2016 Nov;10(9):1318-28. doi: 10.1080/17435390.2016.1210691. Epub 2016 Jul 28.

PMID:
27416974
50.

Persistent Impact of In utero Irradiation on Mouse Brain Structure and Function Characterized by MR Imaging and Behavioral Analysis.

Verreet T, Rangarajan JR, Quintens R, Verslegers M, Lo AC, Govaerts K, Neefs M, Leysen L, Baatout S, Maes F, Himmelreich U, D'Hooge R, Moons L, Benotmane MA.

Front Behav Neurosci. 2016 May 4;10:83. doi: 10.3389/fnbeh.2016.00083. eCollection 2016.

Supplemental Content

Loading ...
Support Center